← Open Payments lookup

BEVERLY ALES: Open Payments

NPI 1174156103 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,753 in 83 payments from 15 companies in 2025. Trend: 2023 $1,501 · 2024 $1,379 · 2025 $1,753

Food & beverage: $1,753
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.18$389
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$263
Neurocrine BioSciences, Inc.7$225
Vanda Pharmaceuticals Inc.8$184
Lundbeck LLC9$140
Boston Scientific Corporation4$103
ABBVIE INC.6$98
Axsome Therapeutics, Inc.4$95
Corium, LLC7$94
E.R. Squibb & Sons, L.L.C.3$54

Products named: REXULTI, CAPLYTA, INGREZZA, FANAPT, VRAYLAR, Auvelity, Azstarys, OBSIDIO.

Industry payments across AL — which companies pay providers there.